25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Wanbangde Pharmaceutical Holding Group Co Ltd
Buy, Hold or Sell?

Let's analyze Wanbangde Pharmaceutical Holding Group Co Ltd together

I guess you are interested in Wanbangde Pharmaceutical Holding Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wanbangde Pharmaceutical Holding Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Wanbangde Pharmaceutical Holding Group Co Ltd

I send you an email if I find something interesting about Wanbangde Pharmaceutical Holding Group Co Ltd.

1. Quick Overview

1.1. Quick analysis of Wanbangde Pharmaceutical Holding Group Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Wanbangde Pharmaceutical Holding Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
97.4%

What is your share worth?

Current worth
¥4.53
Expected worth in 1 year
¥4.56
How sure are you?
89.7%

+ What do you gain per year?

Total Gains per Share
¥0.12
Return On Investment
1.9%

For what price can you sell your share?

Current Price per Share
¥5.98
Expected price per share
¥4.51 - ¥7.2065482758621
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Wanbangde Pharmaceutical Holding Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥5.98
Intrinsic Value Per Share
¥2.01 - ¥2.53
Total Value Per Share
¥6.54 - ¥7.06

2.2. Growth of Wanbangde Pharmaceutical Holding Group Co Ltd (5 min.)




Is Wanbangde Pharmaceutical Holding Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$386m$390.6m-$8.1m-2.1%

How much money is Wanbangde Pharmaceutical Holding Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.9m$2.3m-$416.5k-21.8%
Net Profit Margin1.6%4.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Wanbangde Pharmaceutical Holding Group Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Wanbangde Pharmaceutical Holding Group Co Ltd?

Welcome investor! Wanbangde Pharmaceutical Holding Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Wanbangde Pharmaceutical Holding Group Co Ltd.

First you should know what it really means to hold a share of Wanbangde Pharmaceutical Holding Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Wanbangde Pharmaceutical Holding Group Co Ltd is ¥5.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Wanbangde Pharmaceutical Holding Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Wanbangde Pharmaceutical Holding Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.53. Based on the TTM, the Book Value Change Per Share is ¥0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Wanbangde Pharmaceutical Holding Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.1%0.010.1%0.010.2%0.010.1%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.010.2%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.000.0%0.000.1%0.010.1%0.020.3%0.010.2%
Usd Price Per Share0.58-0.78-1.14-1.33-1.61-
Price to Earnings Ratio73.21-22.33-92.40-594.22-366.78-
Price-to-Total Gains Ratio249.67-68.22-83.36--406.45--10.73-
Price to Book Ratio0.93-1.26-1.80-2.23-4.04-
Price-to-Total Gains Ratio249.67-68.22-83.36--406.45--10.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.827034
Number of shares1209
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.02
Gains per Quarter (1209 shares)4.8122.49
Gains per Year (1209 shares)19.2489.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11469355580
227112871109170
3411747106164260
4542366142218350
5682885177273440
68134104213327530
79540123248382620
810845142284436710
912251161319491800
1013657180354545890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%37.01.01.094.9%69.01.01.097.2%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%13.07.00.065.0%30.09.00.076.9%60.011.00.084.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.00.01.097.4%65.00.06.091.5%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%35.04.00.089.7%66.05.00.093.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Wanbangde Pharmaceutical Holding Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0060.008-29%-0.008+236%0.081-93%0.065-91%
Book Value Per Share--4.5274.484+1%4.571-1%4.355+4%3.381+34%
Current Ratio--1.3781.432-4%1.859-26%1.850-26%1.030+34%
Debt To Asset Ratio--0.3540.364-3%0.342+3%0.385-8%0.301+18%
Debt To Equity Ratio--0.5680.596-5%0.547+4%0.698-19%0.510+11%
Dividend Per Share--0.0110.020-47%0.045-76%0.053-80%0.042-74%
Eps--0.0140.022-36%0.060-76%0.070-80%0.053-73%
Free Cash Flow Per Share--0.0580.042+38%-0.146+352%-0.119+306%-0.055+195%
Free Cash Flow To Equity Per Share--0.0580.042+38%-0.062+207%-0.171+396%-0.091+257%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.974+3%
Intrinsic Value_10Y_max--2.532--------
Intrinsic Value_10Y_min--2.013--------
Intrinsic Value_1Y_max---0.171--------
Intrinsic Value_1Y_min---0.168--------
Intrinsic Value_3Y_max---0.189--------
Intrinsic Value_3Y_min---0.187--------
Intrinsic Value_5Y_max--0.182--------
Intrinsic Value_5Y_min--0.141--------
Market Cap3687800363.520+30%2596260921.5503479667992.838-25%5099165281.908-49%5927268766.280-56%7179980240.250-64%
Net Profit Margin--0.0270.016+72%0.048-43%0.049-44%0.028-3%
Operating Margin----0%0.098-100%0.064-100%0.033-100%
Operating Ratio--1.6081.533+5%1.383+16%1.552+4%1.321+22%
Pb Ratio1.321+30%0.9301.261-26%1.804-48%2.230-58%4.042-77%
Pe Ratio103.991+30%73.21122.325+228%92.397-21%594.217-88%366.784-80%
Price Per Share5.980+30%4.2105.643-25%8.253-49%9.594-56%11.634-64%
Price To Free Cash Flow Ratio25.828+30%18.1838.737+108%-19.204+206%-10.857+160%11.047+65%
Price To Total Gains Ratio354.637+30%249.66968.222+266%83.358+200%-406.449+263%-10.727+104%
Quick Ratio--0.6390.670-5%1.014-37%1.001-36%1.208-47%
Return On Assets--0.0020.003-36%0.004-48%0.008-76%0.010-79%
Return On Equity--0.0030.005-35%0.006-46%0.016-79%0.015-79%
Total Gains Per Share--0.0170.029-41%0.037-54%0.134-87%0.106-84%
Usd Book Value--386093696.295382465279.505+1%390603239.001-1%372036264.501+4%288692201.085+34%
Usd Book Value Change Per Share--0.0010.001-29%-0.001+236%0.011-93%0.009-91%
Usd Book Value Per Share--0.6260.620+1%0.632-1%0.602+4%0.468+34%
Usd Dividend Per Share--0.0010.003-47%0.006-76%0.007-80%0.006-74%
Usd Eps--0.0020.003-36%0.008-76%0.010-80%0.007-73%
Usd Free Cash Flow--4936658.9533567104.381+38%-12448397.168+352%-10177844.812+306%-3503750.399+171%
Usd Free Cash Flow Per Share--0.0080.006+38%-0.020+352%-0.016+306%-0.008+195%
Usd Free Cash Flow To Equity Per Share--0.0080.006+38%-0.009+207%-0.024+396%-0.013+257%
Usd Market Cap510022790.275+30%359062885.450481238083.409-25%705214558.488-49%819741270.376-56%992991267.227-64%
Usd Price Per Share0.827+30%0.5820.780-25%1.141-49%1.327-56%1.609-64%
Usd Profit--1226117.1601912818.331-36%2329369.243-47%5224074.946-77%4083706.130-70%
Usd Revenue--44757375.10253804815.389-17%62021153.967-28%191316596.949-77%308669519.413-85%
Usd Total Gains Per Share--0.0020.004-41%0.005-54%0.019-87%0.015-84%
 EOD+4 -4MRQTTM+14 -20YOY+11 -245Y+14 -2110Y+14 -22

3.3 Fundamental Score

Let's check the fundamental score of Wanbangde Pharmaceutical Holding Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15103.991
Price to Book Ratio (EOD)Between0-11.321
Net Profit Margin (MRQ)Greater than00.027
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.639
Current Ratio (MRQ)Greater than11.378
Debt to Asset Ratio (MRQ)Less than10.354
Debt to Equity Ratio (MRQ)Less than10.568
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.002
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Wanbangde Pharmaceutical Holding Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.294
Ma 20Greater thanMa 505.819
Ma 50Greater thanMa 1004.955
Ma 100Greater thanMa 2004.603
OpenGreater thanClose6.070
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Wanbangde Pharmaceutical Holding Group Co Ltd

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale segments. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells medical devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and protective equipment. In addition, it provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou City, China.

Fundamental data was last updated by Penke on 2024-10-27 16:19:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Wanbangde Pharmaceutical Holding Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.7% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 2.7%. The company is making a profit. +1
  • The TTM is 1.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM1.6%+1.1%
TTM1.6%YOY4.8%-3.2%
TTM1.6%5Y4.9%-3.3%
5Y4.9%10Y2.8%+2.0%
4.3.1.2. Return on Assets

Shows how efficient Wanbangde Pharmaceutical Holding Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Assets means that Wanbangde Pharmaceutical Holding Group Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.3%-0.1%
TTM0.3%YOY0.4%-0.1%
TTM0.3%5Y0.8%-0.5%
5Y0.8%10Y1.0%-0.1%
4.3.1.3. Return on Equity

Shows how efficient Wanbangde Pharmaceutical Holding Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Equity means Wanbangde Pharmaceutical Holding Group Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.5%-0.2%
TTM0.5%YOY0.6%-0.1%
TTM0.5%5Y1.6%-1.1%
5Y1.6%10Y1.5%+0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Wanbangde Pharmaceutical Holding Group Co Ltd is operating .

  • Measures how much profit Wanbangde Pharmaceutical Holding Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.8%-9.8%
TTM-5Y6.4%-6.4%
5Y6.4%10Y3.3%+3.0%
4.3.2.2. Operating Ratio

Measures how efficient Wanbangde Pharmaceutical Holding Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 1.608. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.533. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.608TTM1.533+0.075
TTM1.533YOY1.383+0.150
TTM1.5335Y1.552-0.019
5Y1.55210Y1.321+0.231
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Wanbangde Pharmaceutical Holding Group Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Wanbangde Pharmaceutical Holding Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.38 means the company has ¥1.38 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 1.378. The company is just able to pay all its short-term debts.
  • The TTM is 1.432. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.378TTM1.432-0.055
TTM1.432YOY1.859-0.427
TTM1.4325Y1.850-0.417
5Y1.85010Y1.030+0.820
4.4.3.2. Quick Ratio

Measures if Wanbangde Pharmaceutical Holding Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.64 means the company can pay off ¥0.64 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.639. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.670. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.639TTM0.670-0.031
TTM0.670YOY1.014-0.344
TTM0.6705Y1.001-0.332
5Y1.00110Y1.208-0.206
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Wanbangde Pharmaceutical Holding Group Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Wanbangde Pharmaceutical Holding Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.35 means that Wanbangde Pharmaceutical Holding Group Co Ltd assets are financed with 35.4% credit (debt) and the remaining percentage (100% - 35.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.354. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.364. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.354TTM0.364-0.010
TTM0.364YOY0.342+0.022
TTM0.3645Y0.385-0.021
5Y0.38510Y0.301+0.084
4.5.4.2. Debt to Equity Ratio

Measures if Wanbangde Pharmaceutical Holding Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 56.8% means that company has ¥0.57 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The MRQ is 0.568. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.596. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.568TTM0.596-0.029
TTM0.596YOY0.547+0.049
TTM0.5965Y0.698-0.102
5Y0.69810Y0.510+0.188
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Wanbangde Pharmaceutical Holding Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Wanbangde Pharmaceutical Holding Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 73.21 means the investor is paying ¥73.21 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The EOD is 103.991. Based on the earnings, the company is expensive. -2
  • The MRQ is 73.211. Based on the earnings, the company is expensive. -2
  • The TTM is 22.325. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD103.991MRQ73.211+30.780
MRQ73.211TTM22.325+50.886
TTM22.325YOY92.397-70.072
TTM22.3255Y594.217-571.892
5Y594.21710Y366.784+227.433
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The EOD is 25.828. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 18.183. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 8.737. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD25.828MRQ18.183+7.645
MRQ18.183TTM8.737+9.446
TTM8.737YOY-19.204+27.941
TTM8.7375Y-10.857+19.594
5Y-10.85710Y11.047-21.905
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Wanbangde Pharmaceutical Holding Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Wanbangde Pharmaceutical Holding Group Co Ltd:

  • The EOD is 1.321. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.930. Based on the equity, the company is cheap. +2
  • The TTM is 1.261. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.321MRQ0.930+0.391
MRQ0.930TTM1.261-0.331
TTM1.261YOY1.804-0.543
TTM1.2615Y2.230-0.969
5Y2.23010Y4.042-1.812
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,321,708
Total Liabilities1,529,997
Total Stockholder Equity2,695,880
 As reported
Total Liabilities 1,529,997
Total Stockholder Equity+ 2,695,880
Total Assets = 4,321,708

Assets

Total Assets4,321,708
Total Current Assets1,853,878
Long-term Assets2,467,830
Total Current Assets
Cash And Cash Equivalents 153,502
Net Receivables 859,676
Inventory 268,471
Other Current Assets 28,078
Total Current Assets  (as reported)1,853,878
Total Current Assets  (calculated)1,309,727
+/- 544,151
Long-term Assets
Property Plant Equipment 1,528,312
Goodwill 126,494
Intangible Assets 463,227
Long-term Assets Other 86,511
Long-term Assets  (as reported)2,467,830
Long-term Assets  (calculated)2,204,544
+/- 263,286

Liabilities & Shareholders' Equity

Total Current Liabilities1,345,615
Long-term Liabilities184,382
Total Stockholder Equity2,695,880
Total Current Liabilities
Short Long Term Debt 819,031
Accounts payable 268,370
Other Current Liabilities 125,126
Total Current Liabilities  (as reported)1,345,615
Total Current Liabilities  (calculated)1,212,527
+/- 133,088
Long-term Liabilities
Long term Debt 55,337
Capital Lease Obligations Min Short Term Debt12,491
Long-term Liabilities Other 5,960
Long-term Liabilities  (as reported)184,382
Long-term Liabilities  (calculated)73,787
+/- 110,594
Total Stockholder Equity
Retained Earnings 1,688,443
Total Stockholder Equity (as reported)2,695,880
Total Stockholder Equity (calculated)1,688,443
+/- 1,007,437
Other
Capital Stock616,689
Common Stock Shares Outstanding 616,689
Net Debt 720,866
Net Invested Capital 3,570,248
Net Working Capital 508,263
Property Plant and Equipment Gross 1,528,312



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302005-12-312004-12-312003-12-31
> Total Assets 
261,573
416,656
661,727
841,662
911,689
851,571
824,269
814,933
960,690
927,630
1,157,040
1,205,396
1,248,372
1,021,775
1,085,530
1,043,846
1,221,591
1,118,978
1,285,691
1,224,858
1,295,974
1,316,586
1,349,600
1,447,260
1,568,296
1,446,291
1,512,368
1,586,239
1,640,186
1,566,504
1,699,900
1,594,963
1,564,745
1,548,959
1,566,412
1,558,138
1,602,491
1,551,027
1,541,964
1,579,071
1,625,566
1,617,271
1,602,939
1,607,479
1,608,429
1,658,423
1,673,322
1,654,132
1,651,348
2,100,060
2,046,812
2,469,119
2,588,040
2,683,608
3,177,221
3,620,970
3,821,356
5,082,547
5,069,937
5,113,578
5,662,315
4,208,127
4,046,656
4,106,379
4,371,377
4,171,668
4,032,395
4,165,854
4,215,633
4,434,594
4,375,473
4,380,326
4,296,358
4,406,600
4,321,708
4,321,7084,406,6004,296,3584,380,3264,375,4734,434,5944,215,6334,165,8544,032,3954,171,6684,371,3774,106,3794,046,6564,208,1275,662,3155,113,5785,069,9375,082,5473,821,3563,620,9703,177,2212,683,6082,588,0402,469,1192,046,8122,100,0601,651,3481,654,1321,673,3221,658,4231,608,4291,607,4791,602,9391,617,2711,625,5661,579,0711,541,9641,551,0271,602,4911,558,1381,566,4121,548,9591,564,7451,594,9631,699,9001,566,5041,640,1861,586,2391,512,3681,446,2911,568,2961,447,2601,349,6001,316,5861,295,9741,224,8581,285,6911,118,9781,221,5911,043,8461,085,5301,021,7751,248,3721,205,3961,157,040927,630960,690814,933824,269851,571911,689841,662661,727416,656261,573
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,372,796
1,759,866
2,227,637
841,734
2,900,210
2,728,765
2,797,695
3,081,955
2,407,767
2,199,331
2,230,390
2,468,820
2,216,222
2,047,996
2,136,447
2,200,818
2,375,424
2,185,894
2,173,908
1,923,267
1,915,917
1,853,878
1,853,8781,915,9171,923,2672,173,9082,185,8942,375,4242,200,8182,136,4472,047,9962,216,2222,468,8202,230,3902,199,3312,407,7673,081,9552,797,6952,728,7652,900,210841,7342,227,6371,759,8661,372,79600000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,922
571,187
598,756
650,937
620,748
547,072
288,424
574,183
416,452
185,201
156,094
912,019
696,809
587,438
542,877
467,619
447,359
302,869
317,117
226,608
192,238
153,502
153,502192,238226,608317,117302,869447,359467,619542,877587,438696,809912,019156,094185,201416,452574,183288,424547,072620,748650,937598,756571,187255,92200000000000000000000000000000000000000000000000000000
       Net Receivables 
24,896
32,298
32,701
54,710
97,902
77,692
103,290
91,728
125,491
126,979
160,124
102,726
162,700
68,333
109,374
69,978
151,121
116,120
164,832
138,356
216,524
140,818
277,232
225,764
363,545
317,895
367,202
240,792
308,574
322,508
487,470
421,831
437,195
402,280
455,235
367,468
362,205
344,462
419,077
390,048
490,890
494,382
491,222
421,118
457,748
423,227
446,942
395,739
426,992
490,106
555,242
511,877
638,245
367,384
423,645
647,947
608,807
1,291,649
1,136,194
1,344,978
1,351,590
1,661,999
1,643,680
1,679,020
1,177,603
1,130,211
1,085,683
1,202,999
1,052,712
1,336,435
1,274,427
937,841
961,985
915,789
859,676
859,676915,789961,985937,8411,274,4271,336,4351,052,7121,202,9991,085,6831,130,2111,177,6031,679,0201,643,6801,661,9991,351,5901,344,9781,136,1941,291,649608,807647,947423,645367,384638,245511,877555,242490,106426,992395,739446,942423,227457,748421,118491,222494,382490,890390,048419,077344,462362,205367,468455,235402,280437,195421,831487,470322,508308,574240,792367,202317,895363,545225,764277,232140,818216,524138,356164,832116,120151,12169,978109,37468,333162,700102,726160,124126,979125,49191,728103,29077,69297,90254,71032,70132,29824,896
       Other Current Assets 
3,917
28,180
56,117
95,307
92,245
56,905
111,756
83,524
124,524
73,219
144,292
169,268
166,071
28,057
101,456
41,413
140,764
23,474
196,621
31,435
126,639
17,406
41,198
40,559
156,750
26,452
39,587
116,326
155,869
32,433
120,420
27,182
19,288
38,536
97,274
70,850
76,869
29,686
133,596
47,000
80,472
15,551
127,909
56,729
159,850
26,623
239,423
45,786
37,570
37,829
79,636
212,615
134,272
3,859
13,418
12,051
8,817
268,448
263,249
335,533
301,433
105,795
90,308
91,006
113,656
115,775
91,293
108,234
28,022
313,507
283,599
24,192
31,753
29,622
28,078
28,07829,62231,75324,192283,599313,50728,022108,23491,293115,775113,65691,00690,308105,795301,433335,533263,249268,4488,81712,05113,4183,859134,272212,61579,63637,82937,57045,786239,42326,623159,85056,729127,90915,55180,47247,000133,59629,68676,86970,85097,27438,53619,28827,182120,42032,433155,869116,32639,58726,452156,75040,55941,19817,406126,63931,435196,62123,474140,76441,413101,45628,057166,071169,268144,29273,219124,52483,524111,75656,90592,24595,30756,11728,1803,917
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,310,812
1,417,354
1,393,333
1,621,869
2,182,337
2,341,172
2,315,883
2,580,360
1,800,360
1,847,325
1,875,989
1,902,557
1,955,446
1,984,400
2,029,407
2,014,815
2,059,170
2,189,579
2,206,418
2,373,091
2,490,682
2,467,830
2,467,8302,490,6822,373,0912,206,4182,189,5792,059,1702,014,8152,029,4071,984,4001,955,4461,902,5571,875,9891,847,3251,800,3602,580,3602,315,8832,341,1722,182,3371,621,8691,393,3331,417,3541,310,81200000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
136,767
228,797
308,100
357,630
372,151
351,629
325,974
358,410
403,403
448,581
393,828
528,233
479,287
563,859
515,887
590,275
517,424
588,260
517,676
577,339
496,896
555,121
497,416
620,961
557,442
618,816
571,747
633,831
556,040
603,371
525,270
583,286
503,161
534,179
458,834
454,823
457,963
462,271
456,231
455,161
461,724
451,108
437,934
425,958
413,632
403,549
391,006
380,933
370,211
509,951
507,435
509,870
545,242
584,118
684,745
788,080
304,139
1,320,808
1,492,016
1,524,851
1,738,724
1,043,989
1,090,163
1,157,473
1,175,434
1,189,179
1,214,105
1,249,523
1,274,303
1,311,937
1,423,559
1,435,971
1,495,047
1,513,716
1,528,312
1,528,3121,513,7161,495,0471,435,9711,423,5591,311,9371,274,3031,249,5231,214,1051,189,1791,175,4341,157,4731,090,1631,043,9891,738,7241,524,8511,492,0161,320,808304,139788,080684,745584,118545,242509,870507,435509,951370,211380,933391,006403,549413,632425,958437,934451,108461,724455,161456,231462,271457,963454,823458,834534,179503,161583,286525,270603,371556,040633,831571,747618,816557,442620,961497,416555,121496,896577,339517,676588,260517,424590,275515,887563,859479,287528,233393,828448,581403,403358,410325,974351,629372,151357,630308,100228,797136,767
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
187,469
187,469
187,469
293,303
297,502
299,493
298,112
300,260
291,915
283,563
219,344
217,871
217,449
218,231
216,304
194,787
197,957
195,873
194,367
127,928
125,768
125,836
124,901
125,463
124,960
126,494
126,494124,960125,463124,901125,836125,768127,928194,367195,873197,957194,787216,304218,231217,449217,871219,344283,563291,915300,260298,112299,493297,502293,303187,469187,469187,4690000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
20,864
21,058
20,947
70,796
70,430
70,064
69,689
69,333
68,973
68,603
68,237
67,870
67,504
67,139
66,773
8
66,149
7
65,316
5
64,584
4
63,850
2
63,140
0
62,384
0
61,300
60,937
60,573
60,210
59,847
59,484
59,121
58,758
59,114
58,714
58,313
57,912
57,511
57,110
56,709
327,521
327,731
324,129
477,248
283,745
92,744
281,876
365,779
507,496
504,690
505,740
504,114
414,500
414,804
411,025
417,537
463,612
459,394
455,970
456,165
451,058
454,345
457,178
464,613
462,921
463,227
463,227462,921464,613457,178454,345451,058456,165455,970459,394463,612417,537411,025414,804414,500504,114505,740504,690507,496365,779281,87692,744283,745477,248324,129327,731327,52156,70957,11057,51157,91258,31358,71459,11458,75859,12159,48459,84760,21060,57360,93761,300062,384063,140263,850464,584565,316766,149866,77367,13967,50467,87068,23768,60368,97369,33369,68970,06470,43070,79620,94721,05820,864000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127,185
1,101
3,069
4,815
27,604
21,795
1,552,173
43,998
77,247
70,915
30,859
39,055
28,844
35,386
39,729
44,471
53,046
63,080
66,989
138,687
144,090
86,511
86,511144,090138,68766,98963,08053,04644,47139,72935,38628,84439,05530,85970,91577,24743,9981,552,17321,79527,6044,8153,0691,101127,18500000000000000000000000000000000000000000000000000000
> Total Liabilities 
163,047
280,484
508,844
673,294
732,329
493,849
457,069
436,504
566,300
512,514
494,893
532,035
549,862
309,462
363,077
313,189
455,997
307,386
480,604
378,307
405,894
380,458
391,169
467,068
546,444
392,223
440,557
533,848
570,174
469,092
588,679
470,944
417,047
361,073
362,398
318,126
338,179
254,691
240,315
249,725
271,941
270,282
245,807
243,936
225,874
261,849
268,742
286,032
251,903
496,585
433,094
835,006
913,333
951,739
1,390,678
1,809,317
1,888,018
2,371,283
2,262,595
2,418,498
2,804,191
1,403,470
1,312,063
1,343,806
1,626,694
1,390,803
1,234,403
1,290,433
1,396,526
1,602,606
1,604,716
1,657,095
1,537,385
1,618,612
1,529,997
1,529,9971,618,6121,537,3851,657,0951,604,7161,602,6061,396,5261,290,4331,234,4031,390,8031,626,6941,343,8061,312,0631,403,4702,804,1912,418,4982,262,5952,371,2831,888,0181,809,3171,390,678951,739913,333835,006433,094496,585251,903286,032268,742261,849225,874243,936245,807270,282271,941249,725240,315254,691338,179318,126362,398361,073417,047470,944588,679469,092570,174533,848440,557392,223546,444467,068391,169380,458405,894378,307480,604307,386455,997313,189363,077309,462549,862532,035494,893512,514566,300436,504457,069493,849732,329673,294508,844280,484163,047
   > Total Current Liabilities 
124,967
203,164
478,844
643,294
686,930
470,748
417,168
396,604
517,400
486,714
469,094
506,235
524,062
299,462
353,077
303,439
446,497
298,136
460,266
358,534
386,686
359,992
371,329
447,853
527,854
374,304
423,274
517,202
554,164
449,931
570,263
453,274
400,123
344,894
346,965
303,439
324,238
240,908
227,308
237,494
260,486
256,546
232,927
231,857
214,578
251,229
258,908
276,947
243,642
466,582
403,092
806,877
886,172
925,858
1,054,347
1,276,159
378,022
1,684,062
1,510,160
1,623,511
1,865,050
1,027,427
953,764
987,199
1,283,402
1,113,032
960,502
1,015,980
1,137,256
1,340,579
1,344,259
1,387,674
1,326,611
1,434,183
1,345,615
1,345,6151,434,1831,326,6111,387,6741,344,2591,340,5791,137,2561,015,980960,5021,113,0321,283,402987,199953,7641,027,4271,865,0501,623,5111,510,1601,684,062378,0221,276,1591,054,347925,858886,172806,877403,092466,582243,642276,947258,908251,229214,578231,857232,927256,546260,486237,494227,308240,908324,238303,439346,965344,894400,123453,274570,263449,931554,164517,202423,274374,304527,854447,853371,329359,992386,686358,534460,266298,136446,497303,439353,077299,462524,062506,235469,094486,714517,400396,604417,168470,748686,930643,294478,844203,164124,967
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
528,213
574,488
746,686
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000746,686574,488528,21300000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
528,213
574,488
746,686
784,430
854,717
988,047
1,024,561
1,097,919
566,009
500,865
529,701
570,294
609,976
638,125
674,428
676,557
793,433
833,895
928,108
824,312
866,464
819,031
819,031866,464824,312928,108833,895793,433676,557674,428638,125609,976570,294529,701500,865566,0091,097,9191,024,561988,047854,717784,430746,686574,488528,21300000000000000000000000000000000000000000000000000000
       Accounts payable 
37,874
63,532
242,701
338,535
309,007
165,572
80,927
69,642
77,246
51,888
92,187
142,722
177,699
105,864
199,762
136,028
179,799
148,555
190,119
170,861
128,825
119,705
82,647
59,688
95,125
57,506
56,991
139,241
111,740
104,865
108,793
164,472
202,411
187,176
181,703
159,443
189,673
183,966
167,763
184,134
194,316
192,333
173,227
169,714
131,827
180,102
173,401
183,607
166,451
144,699
139,282
263,810
352,693
249,279
325,742
381,287
108,099
476,435
281,377
294,135
355,609
163,097
183,725
164,865
254,511
160,217
158,581
163,722
231,183
295,077
304,634
266,421
302,553
310,475
268,370
268,370310,475302,553266,421304,634295,077231,183163,722158,581160,217254,511164,865183,725163,097355,609294,135281,377476,435108,099381,287325,742249,279352,693263,810139,282144,699166,451183,607173,401180,102131,827169,714173,227192,333194,316184,134167,763183,966189,673159,443181,703187,176202,411164,472108,793104,865111,740139,24156,99157,50695,12559,68882,647119,705128,825170,861190,119148,555179,799136,028199,762105,864177,699142,72292,18751,88877,24669,64280,927165,572309,007338,535242,70163,53237,874
       Other Current Liabilities 
12,813
24,672
50,823
88,059
66,223
55,976
66,241
72,962
136,654
95,726
83,807
85,413
121,363
73,598
83,315
77,411
156,898
62,781
153,147
68,673
152,861
70,287
98,682
116,165
187,829
58,198
56,783
59,461
127,424
60,066
191,470
63,802
77,712
63,718
86,262
67,997
93,565
46,941
49,545
48,360
61,170
59,213
59,701
62,144
82,751
71,128
85,507
93,341
77,192
223,271
168,370
197,324
128,138
0
4,000
36
56,604
266,530
168,857
264,152
248,262
284,426
226,724
272,421
328,639
321,416
105,169
141,048
40,126
199,225
158,616
92,197
16,050
99,164
125,126
125,12699,16416,05092,197158,616199,22540,126141,048105,169321,416328,639272,421226,724284,426248,262264,152168,857266,53056,604364,0000128,138197,324168,370223,27177,19293,34185,50771,12882,75162,14459,70159,21361,17048,36049,54546,94193,56567,99786,26263,71877,71263,802191,47060,066127,42459,46156,78358,198187,829116,16598,68270,287152,86168,673153,14762,781156,89877,41183,31573,598121,36385,41383,80795,726136,65472,96266,24155,97666,22388,05950,82324,67212,813
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,881
336,331
533,159
677,509
687,221
752,435
794,988
939,142
376,043
358,299
356,607
343,292
277,771
273,901
274,453
259,270
262,027
260,457
269,421
210,774
184,429
184,382
184,382184,429210,774269,421260,457262,027259,270274,453273,901277,771343,292356,607358,299376,043939,142794,988752,435687,221677,509533,159336,33125,88100000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-528,213
-574,488
-746,686
0
0
0
0
0
0
0
0
1,222
1,222
14,046
13,929
13,429
13,712
13,917
14,021
11,989
13,341
12,491
12,49113,34111,98914,02113,91713,71213,42913,92914,0461,2221,22200000000-746,686-574,488-528,21300000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
226,000
454,800
566,800
567,148
626,300
35
5,040
5,067
0
0
12,195
12,705
10,238
9,942
6,484
9,741
9,754
9,570
5,911
5,852
5,960
5,9605,8525,9119,5709,7549,7416,4849,94210,23812,70512,195005,0675,04035626,300567,148566,800454,800226,000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,842
2,540
2,654
22,189
19,243
21,447
21,939
19,886
18,115
21,950
22,565
23,520
22,610
22,682
25,245
0
31,922
38,621
0
0
0
0
000038,62131,922025,24522,68222,61023,52022,56521,95018,11519,88621,93921,44719,24322,1892,6542,5402,84200000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
98,526
125,770
143,302
157,332
167,718
354,017
363,248
374,208
389,716
409,944
656,801
667,534
692,264
705,644
715,387
722,919
757,116
802,892
795,927
836,127
878,014
923,938
954,448
975,088
1,015,848
1,046,882
1,063,745
1,043,044
1,059,197
1,085,691
1,098,741
1,117,598
1,139,752
1,178,209
1,198,609
1,232,354
1,255,123
1,285,740
1,296,060
1,321,951
1,344,405
1,336,864
1,346,365
1,351,379
1,369,724
1,382,800
1,390,283
1,353,030
1,383,834
1,421,513
1,430,559
1,449,113
1,461,218
1,499,953
1,549,616
1,564,603
1,657,467
2,497,563
2,539,880
2,437,008
2,621,652
2,596,298
2,546,970
2,576,689
2,598,358
2,627,246
2,652,613
2,736,793
2,688,086
2,708,922
2,649,517
2,603,378
2,657,693
2,688,278
2,695,880
2,695,8802,688,2782,657,6932,603,3782,649,5172,708,9222,688,0862,736,7932,652,6132,627,2462,598,3582,576,6892,546,9702,596,2982,621,6522,437,0082,539,8802,497,5631,657,4671,564,6031,549,6161,499,9531,461,2181,449,1131,430,5591,421,5131,383,8341,353,0301,390,2831,382,8001,369,7241,351,3791,346,3651,336,8641,344,4051,321,9511,296,0601,285,7401,255,1231,232,3541,198,6091,178,2091,139,7521,117,5981,098,7411,085,6911,059,1971,043,0441,063,7451,046,8821,015,848975,088954,448923,938878,014836,127795,927802,892757,116722,919715,387705,644692,264667,534656,801409,944389,716374,208363,248354,017167,718157,332143,302125,77098,526
   Common Stock
38,000
38,000
53,200
53,200
53,200
83,200
83,200
133,120
133,120
133,120
148,750
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
238,000
360,000
618,223
618,223
618,223
618,223
618,223
618,223
618,223
618,223
618,223
618,223
618,223
0
618,223
616,689
0
0
0
0
0000616,689618,2230618,223618,223618,223618,223618,223618,223618,223618,223618,223618,223618,223360,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000238,000148,750133,120133,120133,12083,20083,20053,20053,20053,20038,00038,000
   Retained Earnings 
40,672
62,515
60,383
72,713
82,790
89,936
97,539
110,057
125,565
143,754
154,083
164,816
189,546
198,150
207,893
215,425
249,622
288,107
281,142
321,342
363,229
399,656
430,166
450,805
491,566
510,203
527,066
506,365
522,517
540,902
553,952
572,809
594,962
623,478
718,796
752,541
775,311
805,927
816,247
842,138
864,592
857,051
866,552
871,566
889,911
902,987
910,470
873,217
904,021
941,700
950,931
976,162
993,013
930,370
972,428
992,765
527,876
1,249,724
1,284,562
1,192,036
1,707,562
1,732,909
1,696,961
1,736,973
1,751,184
1,775,971
1,809,280
1,899,487
1,685,299
1,872,399
1,802,393
1,604,078
1,650,739
1,679,578
1,688,443
1,688,4431,679,5781,650,7391,604,0781,802,3931,872,3991,685,2991,899,4871,809,2801,775,9711,751,1841,736,9731,696,9611,732,9091,707,5621,192,0361,284,5621,249,724527,876992,765972,428930,370993,013976,162950,931941,700904,021873,217910,470902,987889,911871,566866,552857,051864,592842,138816,247805,927775,311752,541718,796623,478594,962572,809553,952540,902522,517506,365527,066510,203491,566450,805430,166399,656363,229321,342281,142288,107249,622215,425207,893198,150189,546164,816154,083143,754125,565110,05797,53989,93682,79072,71360,38362,51540,672
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 0000-25,443-27,5030-26,720-20,693-12,750-25,880-31,077-22,696-25,865-24,212-37,547-34,436-39,891-5,443-14,232-8,882-16,48700000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,541,939
Cost of Revenue-907,265
Gross Profit634,674634,674
 
Operating Income (+$)
Gross Profit634,674
Operating Expense-1,431,538
Operating Income110,401-796,864
 
Operating Expense (+$)
Research Development53,984
Selling General Administrative327,059
Selling And Marketing Expenses0
Operating Expense1,431,538381,042
 
Net Interest Income (+$)
Interest Income2,698
Interest Expense-46,484
Other Finance Cost-1,406
Net Interest Income-45,192
 
Pretax Income (+$)
Operating Income110,401
Net Interest Income-45,192
Other Non-Operating Income Expenses0
Income Before Tax (EBT)29,932110,401
EBIT - interestExpense = -46,484
49,209
95,692
Interest Expense46,484
Earnings Before Interest and Taxes (EBIT)076,415
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax29,932
Tax Provision-3,605
Net Income From Continuing Ops26,32726,327
Net Income49,209
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net045,192
 

Technical Analysis of Wanbangde Pharmaceutical Holding Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Wanbangde Pharmaceutical Holding Group Co Ltd. The general trend of Wanbangde Pharmaceutical Holding Group Co Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Wanbangde Pharmaceutical Holding Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wanbangde Pharmaceutical Holding Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.0595 < 7.1419237844941 < 7.2065482758621.

The bearish price targets are: 5.43 > 5.35 > 4.51.

Tweet this
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wanbangde Pharmaceutical Holding Group Co Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wanbangde Pharmaceutical Holding Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current macd is 0.35297618.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Wanbangde Pharmaceutical Holding Group Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Wanbangde Pharmaceutical Holding Group Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Wanbangde Pharmaceutical Holding Group Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current adx is 45.66.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Wanbangde Pharmaceutical Holding Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wanbangde Pharmaceutical Holding Group Co Ltd. The current sar is 5.5303988.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current rsi is 58.29. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Relative Strength Index (RSI) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wanbangde Pharmaceutical Holding Group Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Wanbangde Pharmaceutical Holding Group Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Stochastic Oscillator ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current cci is 82.36.

Wanbangde Pharmaceutical Holding Group Co Ltd Daily Commodity Channel Index (CCI) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current cmo is 9.76411358.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wanbangde Pharmaceutical Holding Group Co Ltd. The current willr is -52.27272727.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Wanbangde Pharmaceutical Holding Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Williams %R ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wanbangde Pharmaceutical Holding Group Co Ltd.

Wanbangde Pharmaceutical Holding Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current atr is 0.3056072.

Wanbangde Pharmaceutical Holding Group Co Ltd Daily Average True Range (ATR) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current obv is 347,455,605.

Wanbangde Pharmaceutical Holding Group Co Ltd Daily On-Balance Volume (OBV) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wanbangde Pharmaceutical Holding Group Co Ltd. The current mfi is 62.69.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Wanbangde Pharmaceutical Holding Group Co Ltd Daily Money Flow Index (MFI) ChartWanbangde Pharmaceutical Holding Group Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wanbangde Pharmaceutical Holding Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside

6.3. Candlestick Patterns

Wanbangde Pharmaceutical Holding Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wanbangde Pharmaceutical Holding Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.294
Ma 20Greater thanMa 505.819
Ma 50Greater thanMa 1004.955
Ma 100Greater thanMa 2004.603
OpenGreater thanClose6.070
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Wanbangde Pharmaceutical Holding Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Wanbangde Pharmaceutical Holding Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Wanbangde Pharmaceutical Holding Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wanbangde Pharmaceutical Holding Group Co Ltd

I send you an email if I find something interesting about Wanbangde Pharmaceutical Holding Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Wanbangde Pharmaceutical Holding Group Co Ltd.

Receive notifications about Wanbangde Pharmaceutical Holding Group Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.